Cancer BiologyJournal of Experimental & Clinical Cancer ResearchPeer-reviewed
Development of gemcitabine-modified miR-15a as a novel, multimodal treatment strategy to overcome 5-FU and oxaliplatin resistance in colorectal cancer
Anushka Ojha, A.S. Pal, Max Chao…·Jingfang Ju
This paper develops Gem-miR-15a, a gemcitabine-modified microRNA, which overcomes 5-FU and oxaliplatin resistance in colorectal cancer with high potency and low toxicity.
DOI 10.1186/s13046-026-03865-6